1/20
Looks like no tags are added yet.
Project initiation
- Drug development considers scientific & commercial factors
- Initial assessment includes market+research analysis, competitive assessment
Scientific & commercial factors (project initiation)
- Unmet medical need/therapeutic opportunity
- Scientific and technical feasibility
Market analysis
1. Potential patient popu size
2. Disease charac's
↳ Severity + unmet med. need
↳ Acute vs. chronic
3. Existing treatments
4. Access & reimbursement considerations

Competitive assessment
- What are competitors developing?
1. Timing of market entry
2. Potential differentiation

Timing of market entry (competitive assessment)
- First-to-market may provide advantage
- Later entrants can succeed if they offer meaningful improvements

Potential differentiation (competitive assessment)
- Greater efficacy
- Improved safety
- Lower cost/better access

Assay
Labo test or chem analysis used to measure the presence, purity, or quantity of a target substance

Scientific feasibility
1./2. Is the disease+mech well understood?
3. Are biochem tools available?: reliable assays
4. Are there existing drugs?: potential starting pt, comp.
Lead identification + approaches
- Med. chem. requires a starting pt. → lead
- Approaches to identify hits or leads: natural prods, De-novo design, HTS
High-Throughput Screening (HTS)
- Rapid, efficient, automated testing of large compound libraries
- Requires a reliable, automatable assay
- Compounds showing desired activity = "hits" → re-tested & evaluated to become leads

HTS: Co's may maintain large collections containing...
- Compounds prev. synth'ed within the co. or those from commercial/ext sources
- Natural prods or natural-prod-derived compounds

Importance of testing a variety of compounds
- Hard to predict which compounds will be active
- Drug-target int's can be complex & hard to predict
- Ensures chem diversity
- ↑ chance of identifying hits

HTS testing
- Compounds r initially tested under standardized screening conditions (at 1 concen.)
- Assay prods a measurable biolo response
- A predefined activity threshold to identify hits → re-tested
- Large screen can initially prod 100's of hits
- Counter-screens identify nonspecific activity or assay interference
Hit confirmation: removing false positives
- Many initial hits fail confirmation
- Poor solubility
- Causes of apparent activity
- Goal: confirm true activity & eliminate false/misleading hits
Causes of apparent activity (hit confirmation)
- Impurities or decomp. prods
- Aggregation/detergent-like behavior
- Interference w assay signal: colour or fluorescence
Pan-assay interference compounds (PAINS)
- Compounds w structural features associated w assay interference or nonspecific activity
- May appear active in many assays
- PAINS alerts = warning signs, not automatic proof of false activity → require extra testing to confirm true activity
Causes of PAINS
- Redox activity
- Chem reactivity
- Optical interference
Re-testing hits
1. Re-test promising hits w fresh/purified samples
2. Confirm activity is reproducible
3. Test at many concen's
4. Determine concentration-response relationship
5. More active compound → greater effect as concen ↑ up to a max. response
- Pic on desktop

Test hits in other assays
- Test confirmed hits in additional assays
- Determine if activity is:
1. Specific/selective for target
2. Nonspecific or promiscuous
- Eliminates undesirable hits before development
Confirm chemical structure
- Confirm identity & purity of promising hits: NMR or Mass spectroscopy
- Re-synth. compound when appropriate → ensure it retains its biolo activity
- Test structurally related compounds
- Identify structural features important for activity

Hit-to-lead summary
1. HTS (Yes/No) → compounds become hits
2. Counter screen → reject non-specific
3. Database search → reject PAINS
4. "Routine" assay (dose-response) → reject compounds that don't show dose-response
5. Purification, re-synth, re-testing: reject compounds that "misbehave"
6. Synth & test analogs: reject compounds that don't show SAR
- Pic on desktop